Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol versus fluticasone propionate in persistent asthma
RBR-4f9tccPhase 3Recruiting
- Sponsor
- GSK
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in persistent asthma comparing Fluticasone furoate + vilanterol once daily, Fluticasone propionate + salmeterol twice daily and Fluticasone propionate twice daily (3 arms). Started Mar 2015; status: recruiting.
02
Drugs
fluticasonevilanterolfluticasone propionatesalmeterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on RBR-4f9tcc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4f9tcc.